ASTCT is dedicated to advancing the field of hematopoietic cell transplantation and cellular therapy through groundbreaking research, high-quality education, impactful advocacy and clinical excellence.
About ASTCT
Access resources to advance your career, discounts on meetings and opportunities to collaborate with colleagues. For a limited time, join ASTCT through Sept. 30, 2026, to access benefits through Dec. 31, 2027.
Join ASTCT
ASTCT Talks features industry leaders coming together to tackle important subjects in the growing field of transplantation and cellular therapy. You can listen to ASTCT Talks on the following platforms: Spotify, Google Podcasts and Apple Podcasts.
Listen Here
Now Available! Access the latest issue of Transplantation and Cellular Therapy
Read the Journal
As the first installment in the 2026 Johnson&Johnson and Legend CAR T Series, join Dr. Joy Ho and Dr. Marco Davila as they explore the latest advances in in vivo CAR T cell therapy, offering insights from both clinical and translational research perspectives.
Sponsored by Johnson and Johnson and Legend Biotech.
TP53 mutated MDS and AML represent some of the most difficult diseases to treat, with poor prognosis. This webinar uses a case based approach to debate the best transplant approach (including no transplant) for older patients with TP53 mutated disease in different scenarios.
The Clinical Education Conference (CEC) provides a deeper understanding of the diagnostic evaluations and therapeutic treatments for acute and chronic complications of hematopoietic cell transplantation and cellular therapies. During this two-day event, participate in breakout sessions that will dig deeper into case studies and treatments of either the adult or pediatric patient populations. In addition, the CEC offers a track specially designed for beginners (defined as at about one year into their careers in the field).
More Meetings
Review the Guideline
View More
Browse all Education